Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Achuthan
Single Ascending Dose Safety and Pharmacokinetics of CDRI-97/78: First-In-Human Study of a Novel Antimalarial Drug
Malaria Research and Treatment
Epidemiology
Infectious Diseases
Related publications
A First-In-Human Randomized, Double-Blind, Placebo-Controlled, Single- And Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 to Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: A Randomized, Placebo-Controlled First-In-Human Single-Dose Escalation Study
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Correction To: Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-In-Human, Single- And Multiple-Dose Study in Healthy Volunteers
Clinical Drug Investigation
Medicine
Pharmacology
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Dose JPI-289, a Novel Poly (ADP-Ribose) Polymerase-1 Inhibitor in First-In-Human Study of Healthy Volunteers
Clinical Therapeutics
Pharmacology
Single-Dose Safety, Tolerability, and Pharmacokinetics of the Antibiotic GSK1322322, a Novel Peptide Deformylase Inhibitor
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Dose Proportionality and Pharmacokinetics Of carvedilol Sustained-Release Formulation: A single Dose-Ascending 10-Sequence Incomplete Block Study
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment
Antiviral Therapy
Infectious Diseases
Pharmacology
First-In-Human, Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of RO5126766, a First-In-Class Dual MEK/RAF Inhibitor in Patients With Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Pharmacokinetics and Pharmacodynamics of a Human Monoclonal Anti-Fgf23 Antibody (KRN23) in the First Multiple Ascending-Dose Trial Treating Adults With X-Linked Hypophosphatemia
Journal of Clinical Pharmacology
Pharmacology
